Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
91.33
+3.97
+4.54%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Novartis AG (NOVN)
Switzerland
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NOVN | Switzerland | CHF | Delayed | |
| NOVNz | BATS Europe | CHF | Delayed | |
| NVS | NYSE | USD | Real-time | |
| NVSEF | OTC Markets | USD | Delayed | |
| 0QLR | London | CHF | Real-time | |
| NVSN | Mexico | MXN | Delayed |
Add to/Remove from a Portfolio
Add to Watchlist
- Volume: 2,240,296
- Bid/Ask: 91.32 / 91.33
- Day's Range: 89.96 - 91.70
Novartis
91.33
+3.97
+4.54%
- Discussions
- Recent Sentiments
- User Rankings
NOVN User Rankings
This table ranks investing.com users according to the performance of their sentiments for Novartis share prices.
Sign up for a free investing account and share your sentiments to see yourself on our Novartis AG sentiment user ranking table.
Sign up for a free investing account and share your sentiments to see yourself on our Novartis AG sentiment user ranking table.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | Ramon Guache | 3 | 3 | 2 | 66.67 | +18.75% |
| 2 | paris kariotis | 1 | 1 | 1 | 100 | +15.17% |
| 3 | Pascal Demierre | 1 | 1 | 1 | 100 | +12.84% |
| 4 | ALBERTO FERNANDEZ | 1 | 1 | 1 | 100 | +12.5% |
| 5 | Saverio Marulli | 1 | 1 | 1 | 100 | +11.32% |
| 6 | Marcello Breschi | 1 | 1 | 1 | 100 | +9.1% |
| 7 | Thomas Tsiavos | 2 | 2 | 2 | 100 | +8.77% |
| 8 | George Mueller | 1 | 1 | 1 | 100 | +8.5% |
| 9 | Daniel Gheorghe | 2 | 2 | 2 | 100 | +8.14% |
| 10 | Борис Пехов | 1 | 1 | 1 | 100 | +7.85% |
| 11 | Yves Bühler | 1 | 1 | 1 | 100 | +7.77% |
| 12 | Thierry Debus | 1 | 1 | 1 | 100 | +7.7% |
| 13 | Kaushik Shah | 3 | 3 | 3 | 100 | +7.57% |
| 14 | Alexandre Caillet | 1 | 1 | 1 | 100 | +7.51% |
| 15 | Stelios Vogiatzopoulos | 1 | 1 | 1 | 100 | +7.26% |
| 16 | Salvis Lapins | 1 | 1 | 1 | 100 | +7.06% |
| 17 | Riccardo Dinaro | 1 | 1 | 1 | 100 | +7.03% |
| 18 | Dmitry Devin | 1 | 1 | 1 | 100 | +6.8% |
| 19 | Eugene Esselaar | 1 | 1 | 1 | 100 | +6.53% |
| 20 | Arpad Drszabadfi | 1 | 1 | 1 | 100 | +6.27% |
| 21 | Alex Rummel | 1 | 1 | 1 | 100 | +6.1% |
| 22 | Ribero Cortez | 1 | 1 | 1 | 100 | +6.1% |
| 23 | Giuseppe Marsella | 2 | 2 | 2 | 100 | +6.06% |
| 24 | Caro Toinou | 1 | 1 | 1 | 100 | +5.69% |
| 25 | André van Duren | 1 | 1 | 1 | 100 | +5.43% |
| 26 | Sorawit Chan | 1 | 1 | 1 | 100 | +5.43% |
| 27 | Robin Selm | 1 | 1 | 1 | 100 | +5.18% |
| 28 | Markus Eberhart | 1 | 1 | 1 | 100 | +5.02% |
| 29 | Сагит Ибрагимов | 1 | 1 | 1 | 100 | +4.94% |
| 30 | Andrés Caldelari | 1 | 1 | 1 | 100 | +4.73% |
| 31 | Louis Siamos | 1 | 1 | 1 | 100 | +4.64% |
| 32 | Constantino Halkias | 1 | 1 | 1 | 100 | +4.6% |
| 33 | Filipe Serrano | 1 | 1 | 1 | 100 | +4.6% |
| 34 | Rob Schie | 1 | 1 | 1 | 100 | +4.51% |
| 35 | Alejandro souto | 1 | 1 | 1 | 100 | +4.46% |
| 36 | Konstantin Neykov | 1 | 1 | 1 | 100 | +4.45% |
| 37 | Dominik Heumann | 1 | 1 | 1 | 100 | +4.35% |
| 38 | Naghmeh Jalali | 1 | 1 | 1 | 100 | +4.26% |
| 39 | Eitan Kahnim | 1 | 1 | 1 | 100 | +4.19% |
| 40 | fred renoir | 1 | 1 | 1 | 100 | +4.18% |
| 41 | Jose Maria Loinaz Jaime | 1 | 1 | 1 | 100 | +4.08% |
| 42 | Hugues Privé | 1 | 1 | 1 | 100 | +4.05% |
| 43 | Christian Müller | 1 | 1 | 1 | 100 | +4.02% |
| 44 | Kil Ni | 1 | 1 | 1 | 100 | +3.91% |
| 45 | Daniel Scholla | 1 | 1 | 1 | 100 | +3.62% |
| 46 | pierre jouvelot | 1 | 1 | 1 | 100 | +3.47% |
| 47 | jachy josh | 1 | 1 | 1 | 100 | +3.28% |
| 48 | Tiberio Mihail | 1 | 1 | 1 | 100 | +3.24% |
| 49 | Massimo Cavalletti | 1 | 1 | 1 | 100 | +3.17% |
| 50 | Maor Shoham | 1 | 1 | 1 | 100 | +3.14% |
Write your thoughts about Novartis AG
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Lee Taylor
Dec 01, 2021 10:39
Novartis is trading at a value last seen in 2018; the funds released from a Sandoz divestment need to be directed towards further patient innovation from this Swiss Pharma major …
0
0
Lukas Bednall
Sep 28, 2021 15:36
Hi Guys, I have been invested in Novartis for 5 years and have closely followed the pharmaceutical industry for years. I have been very disappointed with the returns and am looking to transfer my portfolio into riskier assets. Upon research, I think I may have found an even better pharmaceutical company going by the name of SpectrumX. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trials for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.
1
3
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review